BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 6235569)

  • 1. Factors influencing immune complex localisation.
    Schrieber L; Penny R
    Rheumatol Int; 1984; 4(3):95-109. PubMed ID: 6235569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the endocytosis of immune complexes.
    van Es LA; Daha MR
    Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of soluble immune complexes on Fc receptor- and C3b receptor-mediated phagocytosis by macrophages.
    Griffin FM
    J Exp Med; 1980 Oct; 152(4):905-19. PubMed ID: 7420024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
    Lucisano Valim YM; Lachmann PJ
    Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells.
    Daha MR; Gorter A; Leijh PJ; Klar N; van Es LA
    Immunology; 1988 Jul; 64(3):375-9. PubMed ID: 2970428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors.
    Ortiz DF; Lansing JC; Rutitzky L; Kurtagic E; Prod'homme T; Choudhury A; Washburn N; Bhatnagar N; Beneduce C; Holte K; Prenovitz R; Child M; Killough J; Tyler S; Brown J; Nguyen S; Schwab I; Hains M; Meccariello R; Markowitz L; Wang J; Zouaoui R; Simpson A; Schultes B; Capila I; Ling L; Nimmerjahn F; Manning AM; Bosques CJ
    Sci Transl Med; 2016 Nov; 8(365):365ra158. PubMed ID: 27856797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytosis of immune complexes by human neutrophils and monocytes: relative importance of Fc and C3b receptors.
    Schorlemmer HU; Hofstaetter T; Seiler FR
    Behring Inst Mitt; 1984 Nov; (76):88-97. PubMed ID: 6240977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Of mice and men: insights into the complexity of mononuclear phagocyte system blockade provided by autoimmune mouse strains.
    Kimberly RP
    J Lab Clin Med; 1991 Mar; 117(3):173-4. PubMed ID: 2002273
    [No Abstract]   [Full Text] [Related]  

  • 9. Mononuclear phagocytes in rheumatoid arthritis: Fc-receptor expression by peripheral blood monocytes.
    Carter SD; Bourne JT; Elson CJ; Hutton CW; Czudek R; Dieppe PA
    Ann Rheum Dis; 1984 Jun; 43(3):424-9. PubMed ID: 6742906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune complexes in autoimmune diseases. Differences in immune complexes detected by cellular receptors for complement and for Fc domains of IgG.
    Díaz-Jouanen E; Salazar JF; Abud-Mendoza C; Alarcón-Segovia D
    Rev Invest Clin; 1980; 32(2):153-63. PubMed ID: 7423073
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
    Taylor RP; Pocanic F; Reist C; Wright EL
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric assay for phagocytosis of human monocytes mediated via Fc gamma-receptors and complement receptor CR1 (CD35).
    Andoh A; Fujiyama Y; Kitoh K; Hodohara K; Bamba T; Hosoda S
    Cytometry; 1991; 12(7):677-86. PubMed ID: 1838328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?
    Nardin A; Lindorfer MA; Taylor RP
    Mol Immunol; 1999; 36(13-14):827-35. PubMed ID: 10698336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.
    Yokoyama I; Waxman F
    Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L; Maini RN
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.
    Kimberly RP; Edberg JC; Merriam LT; Clarkson SB; Unkeless JC; Taylor RP
    J Clin Invest; 1989 Sep; 84(3):962-70. PubMed ID: 2527255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Problems in the demonstration immune complexes].
    Sedlacek HH; Pernice W; Seiler FR
    Internist (Berl); 1980 Apr; 21(4):220-6. PubMed ID: 6448232
    [No Abstract]   [Full Text] [Related]  

  • 18. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
    Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
    J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes.
    Kávai M; Rasmussen JM; Baatrup G; Zsindely A; Svehag SE
    Scand J Immunol; 1988 Jul; 28(1):123-8. PubMed ID: 2969612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of the transfer reaction: tracking immune complexes from erythrocyte complement receptor 1 to macrophages.
    Craig ML; Bankovich AJ; Taylor RP
    Clin Immunol; 2002 Oct; 105(1):36-47. PubMed ID: 12483992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.